IGF-1 LR3 1 MG

GF-1 LR3 (Insulin-like Growth Factor 1 Long Arg3) is a synthetic modified analog of native IGF-1 designed to enhance stability, receptor affinity, and biological activity in research applications. It features a substitution of arginine for glutamic acid at position 3 and an extended N-terminal sequence of 13 amino acids, which reduces binding to IGF-binding proteins and prolongs its half-life to approximately 20-30 hours.

Research involving IGF-1 LR3 commonly explores:

• Its potent stimulation of cell division, protein synthesis, and cellular differentiation, especially in muscle, bone, nerve, and connective tissues.
• Enhancement of muscle hypertrophy and hyperplasia, promoting lean muscle mass and recovery from musculoskeletal injuries.
• Modulation of fat metabolism by increasing glucose and amino acid uptake into cells, supporting reduced adipose tissue and improved insulin sensitivity.
• Potential roles in diabetes management through lowering blood glucose and insulin requirements.
• Its effects in tissue regeneration, cellular growth, and metabolic regulation across various experimental models.
IGF-1 LR3 is provided as a lyophilized powder for laboratory research use only (RUO). It is not intended for diagnostic, therapeutic, or clinical applications and must not be used in humans or animals.

Product details:

• Synonyms: IGF-1 Long R3, Insulin-like Growth Factor-1 Long Arg3
• Purity: ≥98%
• CAS Number: 143045-27-6
• Molecular Formula: C400H625N111O115S9
• Molecular Weight: Approximately 9200 Da
• Appearance: White to off-white lyophilized powder

This product is intended exclusively for scientific research and laboratory investigation in compliance with applicable regulatory guidelines.